Trudeau Vincent, Gandaglia Giorgio, Shiffmann Jonas, Popa Ioana, Shariat Shahrokh F, Montorsi Francesco, Perrotte Paul, Trinh Quoc-Dien, Karakiewicz Pierre I, Sun Maxine
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC;
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC; ; Department of Urology, Vita-Salute, San Raffaele University Milan, Italy;
Can Urol Assoc J. 2014 Sep;8(9-10):E695-701. doi: 10.5489/cuaj.2051.
We compared short-term outcomes and costs between robotic-assisted nephroureterectomy (RANU) and laparoscopic radical nephroureterectomy (LNU) in a large population-based cohort of patients with upper-tract urothelial carcinoma (UTUC).
Overall, 1914 patients with UTUC treated with RANU or LNU between 2008 and 2010 within the Nationwide Inpatient Sample were abstracted. Propensity-score matching was performed to account for inherent differences between patients undergoing RANU and LNU. Multivariable logistic regression models were fitted to compare postoperative complications, blood transfusions, prolonged length of stay, and costs between the 2 procedures.
Overall, a weighted estimate of 1199 (62.6%) and 715 (37.4%) patients received LNU and RANU, respectively. In multivariable analyses no significant differences were observed in postoperative transfusion and length of stay between the 2 surgical approaches (all p > 0.1). However, patients undergoing RANU were less likely to experience any complications compared to their counterparts undergoing LNU (p = 0.04). The utilization of RANU was associated with substantially higher costs compared to the laparoscopic approach. Our study is limited by its retrospective nature and the lack of adjustment for tumour stage and grade.
Our results support the safety and feasibility of RANU for the treatment of UTUC. Indeed, the use of the robotic approach was associated with lower probability of experiencing perioperative complications compared to LNU. On the other hand, the utilization of RANU is associated with higher costs compared to LNU.
我们在一个基于人群的大型上尿路尿路上皮癌(UTUC)患者队列中,比较了机器人辅助肾输尿管切除术(RANU)和腹腔镜根治性肾输尿管切除术(LNU)的短期疗效和成本。
从2008年至2010年全国住院患者样本中,提取了1914例接受RANU或LNU治疗的UTUC患者。进行倾向评分匹配以解释接受RANU和LNU患者之间的固有差异。采用多变量逻辑回归模型比较两种手术的术后并发症、输血情况、住院时间延长以及成本。
总体而言,加权估计分别有1199例(62.6%)和715例(37.4%)患者接受了LNU和RANU。在多变量分析中,两种手术方式在术后输血和住院时间方面未观察到显著差异(所有p>0.1)。然而,与接受LNU的患者相比,接受RANU的患者发生任何并发症的可能性较小(p=0.04)。与腹腔镜手术相比,RANU的使用与更高的成本相关。我们的研究受其回顾性性质以及缺乏对肿瘤分期和分级的调整的限制。
我们的结果支持RANU治疗UTUC的安全性和可行性。实际上,与LNU相比,机器人手术方法的使用与围手术期并发症发生概率较低相关。另一方面,与LNU相比,RANU的使用与更高的成本相关。